Publications (original articles or review articles) published in 2023 from OUS - Rheumatology Research Group
38 publications found
Cardiac Involvement in Systemic and Local Vasculitides: The Value of Noninvasive Multimodality Imaging
Curr Probl Cardiol, 48 (8), 101718
DOI 10.1016/j.cpcardiol.2023.101718, PubMed 37003450
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead280, PubMed 37294870
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study
Rheumatol Int, 43 (6), 1055-1065
DOI 10.1007/s00296-023-05308-3, PubMed 36933069
The phenotype of mixed connective tissue disease patients having associated interstitial lung disease
Semin Arthritis Rheum, 63, 152258 (in press)
DOI 10.1016/j.semarthrit.2023.152258, PubMed 37696231
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
Rheumatology (Oxford), 62 (5), 1887-1894
DOI 10.1093/rheumatology/keac478, PubMed 35997556
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis
Rheumatology (Oxford), 62 (7), 2483-2491
DOI 10.1093/rheumatology/keac660, PubMed 36413079
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
Autoimmun Rev, 22 (4), 103290
DOI 10.1016/j.autrev.2023.103290, PubMed 36746368
OMERACT International Consensus for Ultrasound Definitions of Tenosynovitis in Juvenile Idiopathic Arthritis: Systematic Literature Review and Delphi Process
Arthritis Care Res (Hoboken), 75 (11), 2277-2284
DOI 10.1002/acr.25159, PubMed 37221153
Optimization of Extracellular Vesicle Release for Targeted Drug Delivery
IEEE Trans Nanobioscience, PP (in press)
DOI 10.1109/TNB.2023.3287637, PubMed 37335787
Does the impact of COVID-19 on patients with systemic sclerosis change over time?
Arthritis Care Res (Hoboken) (in press)
DOI 10.1002/acr.25226, PubMed 37667424
Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
Rheumatology (Oxford), 62 (9), 3213-3218
DOI 10.1093/rheumatology/kead152, PubMed 37004177
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Rheumatology (Oxford), 62 (SI), SI91-SI100
DOI 10.1093/rheumatology/keac405, PubMed 35904554
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
RMD Open, 9 (4)
DOI 10.1136/rmdopen-2023-003380, PubMed 37949614
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis
Thorax, 78 (12), 1188-1196
DOI 10.1136/thorax-2023-220541, PubMed 37798114
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
Lupus Sci Med, 10 (2)
DOI 10.1136/lupus-2023-000926, PubMed 37844960
Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study
RMD Open, 9 (3)
DOI 10.1136/rmdopen-2023-003333, PubMed 37648397
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort
Rheumatology (Oxford), 62 (SI), SI54-SI63
DOI 10.1093/rheumatology/keac363, PubMed 35731139
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead481, PubMed 37698987
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
Rheumatology (Oxford), 62 (4), 1559-1567
DOI 10.1093/rheumatology/keac533, PubMed 36099040
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations
ERJ Open Res, 9 (3)
DOI 10.1183/23120541.00602-2022, PubMed 37260456
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002859, PubMed 36796874
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles
Rheumatology (Oxford), 62 (11), 3680-3689
DOI 10.1093/rheumatology/kead111, PubMed 36929918
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
Rheumatology (Oxford), 62 (SI), SI43-SI53
DOI 10.1093/rheumatology/keac325, PubMed 35640959
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
EBioMedicine, 96, 104804
DOI 10.1016/j.ebiom.2023.104804, PubMed 37769433
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
JAMA Dermatol, 159 (8), 837-847
DOI 10.1001/jamadermatol.2023.1729, PubMed 37378994
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology (Oxford), 62 (6), 2178-2188
DOI 10.1093/rheumatology/keac576, PubMed 36222557
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
BMJ Open Respir Res, 10 (1)
DOI 10.1136/bmjresp-2022-001580, PubMed 37709661
Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002815, PubMed 36828644
Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis
Rheumatology (Oxford), 62 (SI2), SI196-SI204
DOI 10.1093/rheumatology/keac293, PubMed 35575380
Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead519, PubMed 37769251
Molecular Communication Transmitter Design in Limited-Capacity Storage Regime
IEEE Trans Nanobioscience, 22 (2), 212-222
DOI 10.1109/TNB.2022.3179317, PubMed 35635824
Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation
Arthritis Rheumatol, 75 (6), 1021-1027
DOI 10.1002/art.42434, PubMed 36580032
Associations between power Doppler ultrasound findings and B-mode synovitis and clinical arthritis in juvenile idiopathic arthritis using a standardised scanning approach and scoring system
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002937, PubMed 36963783
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
Rheumatology (Oxford), 62 (8), 2918-2929
DOI 10.1093/rheumatology/kead014, PubMed 36688692
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
Arthritis Res Ther, 25 (1), 163
DOI 10.1186/s13075-023-03155-y, PubMed 37670401
Preclinical/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences
Lancet Rheumatol, 5 (3), e116-e118
DOI 10.1016/s2665-9913(23)00033-4, PubMed 37701927
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
Rheum Dis Clin North Am, 49 (2), 249-262
DOI 10.1016/j.rdc.2023.01.003, PubMed 37028833
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Ann Rheum Dis, 82 (10), 1286-1295
DOI 10.1136/ard-2023-224116, PubMed 37423647